[1]
A. . Singh, J. . Isher, R. Sehgal, Manju, N. Kumari, and K. Kaur, “Molnupiravir and Favipiravir in the therapeutics of SARS-CoV-2 - A review”, Indian J Pharm Drug Studies, vol. 1, no. 3, pp. 73–78, Nov. 2022, Accessed: Nov. 15, 2026. [Online]. Available: https://mansapublishers.com/ijpds/article/view/3575